Johns Hopkins
 
Introduction
Early Identification
Start Isolation
Contain
HEIC Prevention & Control
  Prevention and Control Surveillance Research Microbiology Services Outbreak Management
  Education Disease Exposures Infectious Diseases Patient and Visitor Information
Antibiotic Management Program
Heic Forum
Who's at HEIC
Home
VRSA - VISA SUMMARY
Updated 11/03

See our article for more information on "Vancomycin (glycopeptide) intermediate Staphylococcus aureus (VISA)"


Introduction

Vancomycin-Resistant Staphylococcus Aureus has the potential to become a prevalent, virulent and transmissible bacterium for which no effective therapy would be available. Due to the severity of this organism, at The John's Hopkins Hospital the VRSA/VISA policy is effective immediately upon identification of a patient with the organism.

• Top of Page
• Back to Prevention & Control


Early Identification

Microbiology
The microbiology lab shall immediately notify Hospital Epidemiology and Infection Control (HEIC), the attending physician or covering attending physician, the nursing unit and the Infectious Disease Consult Service when VISA/VRSA is isolated from a patient specimen.

• Top of Page
• Back to Prevention & Control


Start Isolation

Special Precautions
All patients colonized or infected with VISA/VRSA shall be placed in a private room on Special Precautions. In addition, a standard surgical mask must be worn by all employees, students, volunteers and visitors when caring for such patients with respiratory symptoms and those receiving aerosol treatments (i.e., nebulizations and oxygen).

Infectious Disease Consult
Patients must have an Infectious Disease (ID) Consult. ID will review the patient's antimicrobial therapy.

Limit the Number of Healthcare Workers
The number of healthcare workers (HCWs) who come in contact with the VISA/VRSA patient shall be limited. Healthcare workers known to be at high risk for staphylococcal colonization (those with exfoliative dermatitis) shall not care for patients with VISA/VRSA. Names of all employees, students and volunteers who come in contact with VRSA patients must be monitored by the unit. Until more is learned about the epidemiology of VRSA, all HCWS caring for the patient shall have surveillance cultures for VRSA as organized by HEIC based on the individual circumstances surrounding the patient and his/her care.

A log of individuals entering the patient’s room will be maintained on nursing unit.

• Top of Page
• Back to Prevention & Control


Contain the Spread by Taking Additional Precautions:

  • Hand Hygiene Cleanse with an approved antimicrobial soap or alcohol based waterless hand sanitizer when gloves are removed, before and after patient care, and/or after contact with environmental surfaces.
  • Dedicate Equipment/Supplies., Use disposable supplies that must be discarded when the patient is discharged. Disposable supplies should be transferred with the patient to other units or procedure areas.
  • Limit Patient Transport When possible, preform procedures at the bedside. When transporting paients, Special Precautions must be followed. Evironmental surfaces, such as doorknobs and elevator buttons, can become contaminated during transport. Dedicate one memeber of the transport team to be in contact with environmental surfaces only.
  • Specimen Transport in a double, leakproof bag, hand delivered directly and immediately to the lab. DO NOT SEND SPECIMENS THROUGH THE PNEUMATIC TUBE SYSTEM
  • Thorough Terminal Room Cleaning after the patient is discharged is necessary. The room must remain closed to new admissions until approval by HEIC.

• Top of Page
• Back to Prevention & Control